NCT02523599View on ClinicalTrials.gov

Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

305

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Pain, Postoperative
Interventions
DRUG

XaraColl

Surgical implantation of 3 bupivacaine collagen implants

OTHER

Placebo

Plain collagen implant (vehicle)

Trial Locations (23)

32825

Orlando

33136

Miami

33144

Miami

33331

Weston

33606

Tampa

33713

St. Petersburg

34206

Bradenton

34452

Inverness

34711

Clermont

34741

Kissimmee

35660

Sheffield

36617

Mobile

46202

Indianapolis

48532

Flint

72205

Little Rock

76550

Lampasas

77054

Houston

79935

El Paso

85023

Phoenix

89102

Las Vegas

89106

Las Vegas

91436

Encino

01199

Springfield

Sponsors

Lead Sponsor

Innocoll
All Listed Sponsors
lead

Innocoll

INDUSTRY